Research Use & Compliance
Intended-use positions across the Chemesis catalogue are stated per product in the product documentation.
Pre-launch preview wording · final policy published at launch
Pre-launch preview — catalogue and documentation presented from verified source material · Documentation centre
Catalogue categories
Featured compounds
Documentation centre
28 specification sheets, information packages and technical profiles — downloadable per product.
Browse documents →Intended-use positions across the Chemesis catalogue are stated per product in the product documentation.
Pre-launch preview wording · final policy published at launch
Intended-use positions differ across the catalogue. Some products — including Arecoline Hydrobromide and Glaucine Hydrobromide — are documented strictly for research, analytical and further-manufacturing use, and are not offered as finished dietary supplements, foods or drugs, nor for direct human consumption. Other products are documented as bulk ingredients for functional food, beverage, dietary-supplement or industrial manufacturing. The position for each material is stated in its product information package.
Product documentation states that downstream finished-product claims and regulatory status are the responsibility of the purchaser. Buyers should review the intended-use statement for each material against their own regulatory framework before use.
Safety data sheets supplied with each product describe hazards, handling, storage and transport requirements. Materials should be handled only by qualified personnel under appropriate controls.
Where this website and the supplied product documentation differ, the supplied documentation prevails. Nothing on this website strengthens or extends the statements contained in the source documents.
Looking for product-specific positions? Each product page states its documented intended use, and the documentation centre carries the source documents.